Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank79
3Y CAGR+34.4%
5Y CAGR+3.2%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+34.4%/yr
Annual compound
5Y CAGR
+3.2%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
4 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.22+47.3%
20240.15+38.6%
20230.11+19.0%
20220.09+30.4%
20210.07-63.0%
20200.18-5.9%
20190.20-
20180.00-100.0%
20170.03-42.1%
20160.05-